Index by author
July 01, 2013; Volume 65,Issue 3
Benson, Helen E.
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate LigandsAnthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. HarmarEliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179
Boison, Detlev
- You have accessAdenosine Kinase: Exploitation for Therapeutic GainDetlev BoisonStephen P.H. Alexander, ASSOCIATE EDITOR, Robert Stone Dow Neurobiology Laboratories, Legacy Research Institute, Portland, OregonPharmacological Reviews July 2013, 65 (3) 906-943; DOI: https://doi.org/10.1124/pr.112.006361
Bonner, Tom I.
- You have accessInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate LigandsAnthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. HarmarEliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179
In this issue
Advertisement